Cardiovascular Syst
(CSII)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,864 | 71,070 | 75,333 | 73,783 | 92,671 |
| Marketable Securities | 120,753 | 135,968 | 135,734 | 151,272 | 130,266 |
| Receivables | 36,449 | 40,033 | 38,056 | 32,526 | 29,973 |
| Inventories | 33,127 | 32,313 | 33,367 | 32,506 | 29,152 |
| TOTAL | $263,137 | $284,669 | $285,345 | $293,081 | $285,431 |
| Non-Current Assets | |||||
| PPE Net | 28,788 | 28,894 | 28,157 | 28,123 | 28,232 |
| Investments And Advances | 0 | 20,657 | 0 | 0 | 0 |
| Intangibles | 16,772 | 15,376 | 15,694 | 15,998 | 16,302 |
| Other Non-Current Assets | 23,573 | 2,971 | 17,739 | 11,734 | 11,758 |
| TOTAL | $69,133 | $67,898 | $61,590 | $55,855 | $56,292 |
| Total Assets | $332,270 | $352,567 | $346,935 | $348,936 | $341,723 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,911 | 14,061 | 12,644 | 13,669 | 13,419 |
| Accrued Expenses | 27,639 | 38,189 | 35,541 | 32,338 | 30,192 |
| TOTAL | $43,038 | $54,650 | $50,447 | $48,085 | $45,702 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,527 | 20,596 | 20,663 | 20,716 | 20,767 |
| Deferred Revenues | 2,488 | 2,400 | 2,262 | 2,078 | 2,091 |
| Other Non-Current Liabilities | 3,945 | 4,169 | 2,471 | 2,659 | 2,749 |
| TOTAL | $26,040 | $26,959 | $26,037 | $27,019 | $27,616 |
| Total Liabilities | $69,078 | $81,609 | $76,484 | $75,104 | $73,318 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,551 | 40,208 | 40,162 | 40,192 | 40,125 |
| Common Shares | 39 | 39 | 39 | 39 | 39 |
| Retained earnings | -394,988 | -381,380 | -376,037 | -369,024 | -368,561 |
| Other shareholders' equity | -6 | 11 | 43 | 115 | 200 |
| TOTAL | $263,192 | $270,958 | $270,451 | $273,832 | $268,405 |
| Total Liabilities And Equity | $332,270 | $352,567 | $346,935 | $348,936 | $341,723 |